組織学と細胞学の世界市場- 検査タイプ別、製品別、用途別、地域別、競合別、2020～2030年の産業規模、シェア、動向、機会、予測

組織学と細胞学の世界市場は、2024年に173億7,000万米ドルと評価され、2030年のCAGRは13.19%で、予測期間には366億1,000万米ドルに達すると予測されています。

細胞学は細胞の構造、機能、理解に関する生命科学の一セグメントであり、組織学は生命体の細胞や組織の顕微鏡解剖学に関するものです。組織学と細胞学の世界は、動物や植物の組織や細胞の構造を、特に顕微鏡レベルで説明することに努めています。細胞診は、その迅速な検査速度、正確さ、手頃な価格、高い疾患罹患率と子宮頸部スクリーニングのための検査の使用により、非常に人気があります。子宮頸部疾患、炎症性疾患、がん、自己免疫疾患など、多くの感染症や細胞性疾患の診断が、組織学と細胞学の世界を使用して調査されています。組織学と細胞学の世界市場は、このような臨床研究を通じて多くの疾患を診断することができるため、ヘルスケア産業で大きな成長を遂げています。組織学と細胞学の世界を使用することで、子宮頸部疾患、がん、異常増殖、肝炎、炎症性疾患、下痢、白血病、天然痘、狂犬病など、多くの感染症を特定することができます。商業的な観点からは、細胞診と組織診は診断と調査の手順で使用されます。市場動向は、これらの臨床処置のための試薬やキットの開発に対するメーカーの選好とともに決定されます。

デジタル病理学、AI支援イメージング、自動スライド作製など、診断ラボにおける先端技術の採用が増加していることが、世界の組織学と細胞学市場の成長をさらに促進しています。これらの技術革新は診断精度を高め、手作業によるミスを減らし、ワークフロー効率を向上させています。さらに、テレパソロジーの統合により、病理医が遠隔でスライドを検査できるようになり、これは特に農村部やサービスが行き届いていない地域で有益であるため、高品質の診断へのアクセスが世界的に拡大しています。

主要市場促進要因

がん罹患率の増加

主要市場課題

技術の複雑さとコスト

主要市場動向

リキッドバイオプシーと循環バイオマーカー

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の組織学と細胞学市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 検査タイプ別（組織学、細胞学）
  • 製品別（機器・分析ソフトウェアシステム、消耗品・試薬）
  • 用途別（創薬・設計、臨床診断、調査）
  • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
  • 企業別（2024年）
• 市場マップ
• 検査タイプ別
• 製品別
• 用途別
• 地域別

第6章 北米の組織学と細胞学市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の組織学と細胞学市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋の組織学と細胞学市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の組織学と細胞学市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの組織学と細胞学市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品上市

第13章 世界の組織学と細胞学市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 産業内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Kimberly Hologic, Inc.
• F Hoffmann-La Roche AG.
• Abbott Laboratories Inc.
• Becton Dickinson & Co.
• Danaher Corporation
• Merck KGaA.
• Thermo Fisher Scientific, Inc.
• Sysmex Corporation
• Trivitron Healthcare.
• Koninklijke Philips N.V.

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Histology and Cytology Market was valued at USD 17.37 billion in 2024 and is expected to reach USD 36.61 billion in the forecast period with a CAGR of 13.19% through 2030. Cytology is a branch of life science concerned with the structure, function, and understanding of cells, whereas histology is concerned with the microscopic anatomy of cells and tissues of life forms. Histology and cytology strive to explain the structure of animal and plant tissues and cells, particularly at the microscopic level. Cytology is quite popular due to its rapid examination rate, precision, and affordability, as well as the high disease prevalence and use of the test for cervix screening. The diagnosis of numerous infectious and cell-based disorders, such as cervical diseases, inflammatory diseases, cancer, and autoimmune diseases, is investigated using histology and cytology. The histology and cytology market has been witnessing massive growth in the healthcare industry as a number of diseases can be diagnosed through these clinical studies. With the aid of histology and cytology, a number of infectious diseases can be identified such as cervical disease, cancer, abnormal growth, hepatitis, inflammatory diseases, diarrhea, leukemia, smallpox, rabies etc. From the commercial perspective, cytology and histology are used in the diagnostic and research procedure. The market trends are determined along with the manufacturer's preference for the development of reagents and kits for these clinical procedures.

The increasing adoption of advanced technologies in diagnostic laboratories, such as digital pathology, AI-assisted imaging, and automated slide preparation, is further propelling the growth of the global histology and cytology market. These innovations enhance diagnostic accuracy, reduce manual errors, and improve workflow efficiency. Additionally, the integration of telepathology allows pathologists to remotely examine slides, which is especially beneficial in rural or underserved areas, thereby expanding access to high-quality diagnostics globally.

Key Market Drivers

Increasing prevalence of cancer

The rising global cancer burden is a major factor accelerating the growth of the Global Histology and Cytology Market. These medical disciplines, which focus on the microscopic examination of cells and tissues, are crucial for early and accurate cancer diagnosis. As cancer incidence continues to climb, particularly among aging populations, the demand for histopathological and cytological evaluations is growing rapidly. According to the International Agency for Research on Cancer (IARC), in 2022 there were approximately 20 million new cancer cases and 9.7 million cancer-related deaths globally figures expected to increase substantially in the coming decades.

Furthermore, the number of cancer screening procedures is rising, particularly in emerging economies with expanding healthcare infrastructure. Cytological methods such as the Pap smear remain essential for cervical cancer screening. According to the World Health Organization (WHO), over 90% of cervical cancer cases are preventable and treatable if detected early and managed appropriately placing histology and cytology at the heart of global cancer control strategies. The increased use of biopsy techniques to assess tumors has also led to a surge in histopathological evaluations, further driving market demand. Combined with advances in digital pathology, AI-powered diagnostics, and molecular cytology, these trends ensure strong growth for histology and cytology technologies in oncology.

In addition to diagnostics, the role of histology and cytology in therapeutic monitoring is gaining prominence. As more cancer patients undergo treatments like chemotherapy, immunotherapy, or targeted therapy, regular assessment of tissue samples helps monitor treatment response and detect any recurrence or resistance. This has fueled the integration of advanced cytological imaging systems and histological staining technologies in clinical laboratories and hospitals. The demand for accurate pathological interpretation has also led to growing collaborations between hospitals and diagnostic centers, further expanding access to histology and cytology services.

Key Market Challenges

Technological Complexity and Costs

Advanced histology and cytology technologies often require significant upfront investments in terms of equipment, software, training, and infrastructure. This can be a barrier for smaller clinics, hospitals, and research facilities with limited financial resources. The high initial investment can lead to slower adoption rates, especially in regions with budget constraints. Utilizing complex histology and cytology technologies requires a skilled workforce with specialized training. Training pathologists, technicians, and clinicians to effectively use and interpret data from these technologies can be time-consuming and costly. The scarcity of skilled personnel can further impede technology adoption. Technologically advanced equipment typically requires regular maintenance and updates to ensure optimal performance. The costs associated with maintenance, repairs, and software updates can add to the overall expenses for healthcare institutions. This ongoing financial commitment can be a deterrent, particularly for smaller facilities. Integrating new technology into existing healthcare systems and workflows can be challenging. Compatibility issues with existing systems and processes may arise, requiring additional investments in software development and integration solutions. These challenges can delay technology implementation and adoption.

Key Market Trends

Liquid Biopsies and Circulating Biomarkers

Liquid biopsies involve the analysis of biomarkers, such as circulating tumor DNA (ctDNA) or circulating tumor cells (CTCs), present in blood or other bodily fluids. They enable early detection of diseases, including cancer, even before traditional symptoms manifest. This capability drives the demand for histology and cytology services that can identify and analyze these biomarkers accurately. Unlike traditional tissue biopsies, which require invasive procedures, liquid biopsies are minimally invasive. This approach reduces patient discomfort, risk, and recovery time. As liquid biopsies gain prominence, the demand for traditional histological and cytological procedures might decline for certain applications, but histology and cytology techniques are still essential for validating liquid biopsy results and providing comprehensive diagnoses. Liquid biopsies are often used in conjunction with traditional histology and cytology techniques. They can provide additional information about tumor heterogeneity, genetic mutations, and treatment responses that might not be apparent through tissue biopsies alone. The integration of liquid biopsy data enhances the overall diagnostic accuracy and treatment decision-making process. Circulating biomarkers provide valuable information about a patient's tumor characteristics, enabling the development of personalized treatment strategies. This demand for personalized medicine supports the growth of the histology and cytology market, as these techniques remain essential for understanding tissue-level details and providing comprehensive patient care.

Key Market Players

• Hologic, Inc.
• F Hoffmann-La Roche AG.
• Abbott Laboratories Inc.
• Becton Dickinson & Co.
• Danaher Corporation.
• Merck KGaA.
• Thermo Fisher Scientific, Inc.
• Sysmex Corporation.
• Trivitron Healthcare.
• Koninklijke Philips N.V.

Report Scope:

In this report, the Global Histology and Cytology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Histology and Cytology Market, By Type of Examination:

• Histology
• Cytology

Histology and Cytology Market, By Product:

• Instruments and Analysis Software System
• Consumable and Reagents

Histology and Cytology Market, By Application:

• Drug Discovery & Designing
• Clinical Diagnostics
• Research

Histology and Cytology Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Histology and Cytology Market.

Available Customizations:

Global Histology and Cytology market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Histology and Cytology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type Of Examination (Histology, Cytology)
  • 5.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 5.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.5. By Company (2024)
• 5.3. Market Map
• 5.3.1 By Type of Examination
• 5.3.2 By Product
• 5.3.3 By Application
• 5.3.4 By Region

6. North America Histology and Cytology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type Of Examination (Histology, Cytology)
  • 6.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 6.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Histology and Cytology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type of Examination
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Histology and Cytology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type of Examination
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Histology and Cytology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type of Examination
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Application

7. Europe Histology and Cytology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type Of Examination (Histology, Cytology)
  • 7.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 7.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Histology and Cytology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type of Examination
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Application
  • 7.3.2. Germany Histology and Cytology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type of Examination
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Histology and Cytology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type of Examination
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Histology and Cytology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type of Examination
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Histology and Cytology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type of Examination
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Application

8. Asia-Pacific Histology and Cytology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type Of Examination (Histology, Cytology)
  • 8.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 8.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Histology and Cytology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type of Examination
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Application
  • 8.3.2. India Histology and Cytology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type of Examination
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Histology and Cytology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type of Examination
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Histology and Cytology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type of Examination
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Histology and Cytology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type of Examination
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Application

9. South America Histology and Cytology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type Of Examination (Histology, Cytology)
  • 9.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 9.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Histology and Cytology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type of Examination
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Application
  • 9.3.2. Argentina Histology and Cytology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type of Examination
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Application
  • 9.3.3. Colombia Histology and Cytology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type of Examination
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Application

10. Middle East and Africa Histology and Cytology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type Of Examination (Histology, Cytology)
  • 10.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 10.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Histology and Cytology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type of Examination
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Application
  • 10.3.2. Saudi Arabia Histology and Cytology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type of Examination
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Application
  • 10.3.3. UAE Histology and Cytology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type of Examination
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Histology And Cytology Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Kimberly Hologic, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. F Hoffmann-La Roche AG.
• 15.3. Abbott Laboratories Inc.
• 15.4. Becton Dickinson & Co.
• 15.5. Danaher Corporation.
• 15.6. Merck KGaA.
• 15.7. Thermo Fisher Scientific, Inc.
• 15.8. Sysmex Corporation.
• 15.9. Trivitron Healthcare.
• 15.10. Koninklijke Philips N.V.

16. Strategic Recommendations

17. About Us & Disclaimer